Log in
Enquire now
‌

US Patent 10793505 Unit and process for purification of crude methyl methacrylate

Patent 10793505 was granted and assigned to Arkema on October, 2020 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Arkema
Arkema
Current Assignee
Arkema
Arkema
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10793505
Date of Patent
October 6, 2020
Patent Application Number
15029300
Date Filed
October 17, 2014
Patent Citations Received
‌
US Patent 11873309 Heterocyclic compounds as immunomodulators
0
‌
US Patent 11535615 Heterocyclic compounds as immunomodulators
‌
US Patent 11414433 Heterocyclic compounds as immunomodulators
‌
US Patent 11866451 Salts and crystalline forms of a PD-1/PD-L1 inhibitor
0
‌
US Patent 11465981 Heterocyclic compounds as immunomodulators
‌
US Patent 11566026 Heterocyclic compounds as immunomodulators
‌
US Patent 11572366 Heterocyclic compounds as immunomodulators
‌
US Patent 10906920 Heterocyclic compounds as immunomodulators
...
Patent Primary Examiner
‌
Jonathan Miller
No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10793505 Unit and process for purification of crude methyl methacrylate

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.